Yanhong Zhang is a Principal Scientist in the Drug Substance Technology group within the Technical Development Organization at BioMarin. She obtained her PhD in Biophysics from Medical College of Wisconsin before joining BioMarin. Yanhong has over 15 years of experience in downstream process development and scale-up/technology transfer for recombinant protein therapeutics and gene therapy vectors.

Talks

• Removal of empty AAV capsids to undetectable levels using orthogonal purification steps – Product quality and process robustness considerations